Quinazoline based HDAC dual inhibitors as potential anti-cancer agents
J Dhuguru, OA Ghoneim - Molecules, 2022 - mdpi.com
Cancer is the most devastating disease and second leading cause of death around the
world. Despite scientific advancements in the diagnosis and treatment of cancer which can …
world. Despite scientific advancements in the diagnosis and treatment of cancer which can …
New Quinazolin-4(3H)-one Derivatives Incorporating Hydrazone and Pyrazole Scaffolds as Antimicrobial Agents Targeting DNA Gyraze Enzyme
EM Mohi El-Deen, ES Nossier, EA Karam - Scientia Pharmaceutica, 2022 - mdpi.com
The present work includes the synthesis of a new series of quinazolin-4 (3 H)-one
compounds (4a–f, 5a–d) as antimicrobial agents. The starting compound, 2 …
compounds (4a–f, 5a–d) as antimicrobial agents. The starting compound, 2 …
Development of novel ecto-nucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) inhibitors for tumor immunotherapy
X Wang, X Lu, D Yan, Y Zhou, X Tan - International Journal of Molecular …, 2022 - mdpi.com
The cyclic guanosine monophosphate–adenosine monophosphate synthase–stimulator of
interferon genes–TANK-binding kinase 1–interferon regulating factor 3 (cGAS-STING-TBK1 …
interferon genes–TANK-binding kinase 1–interferon regulating factor 3 (cGAS-STING-TBK1 …
An oleanolic acid derivative, K73‐03, inhibits pancreatic cancer cells proliferation in vitro and in vivo via blocking EGFR/Akt pathway
Z Zhou, Y Dong, N Li, M Niu, S Wang… - Cell Biology …, 2022 - Wiley Online Library
Oleanolic acid (OA) and its derivatives show potent anticancer function. Pancreatic cancer
(PC) is the fourth core motive of cancer‐related deaths worldwide. Epidermal growth factor …
(PC) is the fourth core motive of cancer‐related deaths worldwide. Epidermal growth factor …
Study of the anticancer effect of new quinazolinone hydrazine derivatives as receptor tyrosine kinase inhibitors
The advent of novel receptor tyrosine kinase inhibitors has provided an important
therapeutic tool for cancer patients. In this study, a series of quinazolinone hydrazide triazole …
therapeutic tool for cancer patients. In this study, a series of quinazolinone hydrazide triazole …
Synthesis, antitumor activity, 3D-QSAR and molecular docking studies of new iodinated 4-(3 H)-quinazolinones 3 N-substituted
M Pérez-Fehrmann, V Kesternich, A Puelles… - RSC …, 2022 - pubs.rsc.org
A novel series of 6-iodo-2-methylquinazolin-4-(3H)-one derivatives, 3a–n, were synthesized
and evaluated for their in vitro cytotoxic activity. Compounds 3a, 3b, 3d, 3e, and 3h showed …
and evaluated for their in vitro cytotoxic activity. Compounds 3a, 3b, 3d, 3e, and 3h showed …
Synthesis and tyrosinase inhibitory activities of novel isopropylquinazolinones
A Hashemi, M Noori, N Dastyafteh, SE Sadat-Ebrahimi… - BMC chemistry, 2023 - Springer
To find new anti-browning and whitening agents in this study, new series of
isopropylquinazolinone derivatives were designed and synthesized. All derivatives were …
isopropylquinazolinone derivatives were designed and synthesized. All derivatives were …
[PDF][PDF] SYNTHESIS, In-vitro CYTOTOXICITY AND IN SILICO INVESTIGATIONS OF QUINAZOLINONE INTEGRATED CHALCONES: AS NOVEL POTENTIAL DUAL …
PK Arora, S Kumar, SK Bansal… - Rasayan Journal of …, 2023 - rasayanjournal.co.in
The present study focuses on the synthesis of some 2-methoxyphenylquinazolin-4-one
incorporated chalcone hybrids to evaluate their cytotoxic potential by MTT assay, and their …
incorporated chalcone hybrids to evaluate their cytotoxic potential by MTT assay, and their …
[HTML][HTML] ПОИСК МУЛЬТИТАРГЕТНЫХ ВЕЩЕСТВ С АНТИМИКРОБНЫМ ЭФФЕКТОМ–ПЕРСПЕКТИВНОЕ НАПРАВЛЕНИЕ СОВРЕМЕННОЙ …
АА Старикова, ДВ Мережкина… - … вестник медицины и …, 2024 - cyberleninka.ru
Представлен обзор литературных данных о принципах создания мультитаргетных
препаратов и механизмах их действия. Проведен анализ результатов изучения …
препаратов и механизмах их действия. Проведен анализ результатов изучения …